Dive in
We have our own point of view on the people, technologies, and conversations that will shape the future.
In the face of a national emergency in child and adolescent mental health, urgent measures are needed to help those in need.
Attention Digital Health Founders: We are now accepting applications to attend the Digital Health Founder’s Fellowship
Opioid use disorder (OUD) is an epidemic that will define our generation. Roughly 90 million Americans use opioids and over 10 million misuse them.
We believe purpose-built vertical SaaS will help make drug discovery more effective and efficient and ultimately improve healthcare outcomes.
At Menlo, we believe the pace of innovation in new medicines will continue to accelerate, powered by the combination of advances in biology, advances in information technology, and even the lasting implications of the global pandemic.
Here at Menlo, we are building an investing practice focused on three of the most exciting areas of healthcare: therapeutic platforms, digital health, and transformative technologies.
Nearly half of U.S. adults—108 million people—have high blood pressure, which is the #1 controllable risk for both heart disease and stroke, the two leading worldwide causes of death.
H1 is a unique healthcare data SaaS company with proprietary data, compelling initial applications, and potential to expand.
The pandemic’s pressures compressed trends toward digital and virtual care that might otherwise have taken years into a few months.
Congratulations to Bernard Coulie and the team at Pliant Therapeutics on a successful IPO!
In order to fulfill the promise of improving healthcare outcomes, electronic medical records (EMRs) must be both portable and private.
How can we take a critical process and make it better? Many successful companies are built from answering this question.
It’s rare to meet an entrepreneur who demonstrates both an incredible command of their business and such a clear vision of the magnitude of the opportunity.
Today, the Aspen Institute announced its fifth class of Health Innovators Fellows, comprised of 21 healthcare leaders from across the industry with diverse expertise.
The Menlo team is thrilled to announce we have added a new partner, Greg Yap, to lead investments in the health, medical, and life science technology space.
